Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00974623Terminated

Bone Graft Materials Observational Registry

Role: collaborator

NCT01452022Not ApplicableCompleted

Performance of Inductigraft in Spinal Fusion

Role: collaborator

NCT01018771Not ApplicableCompleted

Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion

Role: collaborator

NCT01013389Not ApplicableCompleted

Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion (PLIF) With Interbody Fusion

Role: collaborator

All 4 trials loaded